Found: 53
Select item for more details and to access through your institution.
Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1993, v. 85, n. 22, p. 1828, doi. 10.1093/jnci/85.22.1828
- By:
- Publication type:
- Article
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Genetic Analysis as an Aid in Diagnosis for Patients With Midline Carcinomas of Uncertain Histologies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1991, v. 83, n. 5, p. 341, doi. 10.1093/jnci/83.5.341
- By:
- Publication type:
- Article
BOOK REVIEWS.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 2, p. 136
- By:
- Publication type:
- Article
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.
- Published in:
- BJU International, 2011, v. 107, n. 5, p. 844, doi. 10.1111/j.1464-410X.2010.09517.x
- By:
- Publication type:
- Article
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 102, n. 9 Pt. B, p. 1339, doi. 10.1111/j.1464-410X.2008.07980.x
- By:
- Publication type:
- Article
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 16, doi. 10.1093/jjco/hyac155
- By:
- Publication type:
- Article
Arsenic Trioxide in Recurrent Urothelial Cancer: A Cancer and Leukemia Group B Phase II Trial (CALGB 99903).
- Published in:
- Clinical Genitourinary Cancer, 2009, v. 7, n. 3, p. E66, doi. 10.3816/CGC.2009.n.026
- By:
- Publication type:
- Article
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 3, p. e178, doi. 10.1016/j.clgc.2020.12.002
- By:
- Publication type:
- Article
CHEMOTHERAPY FOR METASTATIC BLADDER CANCER.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S60
- By:
- Publication type:
- Article
THE USE OF PROSTATE SPECIFIC ANTIGEN IN MANAGING PATIENTS WITH PROSTATE CANCER.
- Published in:
- Lebanese Medical Journal, 2010, v. 58, p. S57
- By:
- Publication type:
- Article
Somatic mutation of fibroblast growth factor receptor-3 ( FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.
- Published in:
- Journal of Pathology, 2011, v. 224, n. 2, p. 270, doi. 10.1002/path.2892
- By:
- Publication type:
- Article
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 11, p. 2401, doi. 10.1007/s00345-019-02692-z
- By:
- Publication type:
- Article
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Phase III randomized trial of interleukin-2 with or without lymphokine-activated killer cells in the treatment of patients with advanced renal cell carcinoma.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Suramin for germ cell tumors. In vitro growth inhibition and results of a phase II trial.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Two-drug therapy in patients with metastatic germ cell tumors.
- Published in:
- 1991
- By:
- Publication type:
- journal article
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
- Published in:
- Investigational New Drugs, 2007, v. 25, n. 3, p. 265, doi. 10.1007/s10637-006-9020-9
- By:
- Publication type:
- Article
Assessment of Risk in Metastatic Testis Carcinoma: Impact on Treatment.
- Published in:
- Urologia Internationalis, 1991, v. 46, n. 3, p. 298, doi. 10.1159/000282155
- By:
- Publication type:
- Article
A phase II trial of durvalumab and tremelimumab in metastatic, non‐urothelial carcinoma of the urinary tract.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 3, p. 1074, doi. 10.1002/cam4.3699
- By:
- Publication type:
- Article
The Indication for Postchemotherapy Lymph Node Dissection in Clinical Stage IS Nonseminomatous Germ Cell Tumor.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 4, p. 800, doi. 10.1002/cncr.23233
- By:
- Publication type:
- Article
Phase II trial of dose‐dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal functionPresented in part at the American Society of Clinical Oncology 2005 Annual Meeting.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 3, p. 549, doi. 10.1002/cncr.22454
- By:
- Publication type:
- Article
Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract.
- Published in:
- Cancer (0008543X), 2000, v. 88, n. 7, p. 1671, doi. 10.1002/(SICI)1097-0142(20000401)88:7<1671::AID-CNCR22>3.0.CO;2-A
- By:
- Publication type:
- Article
Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.
- Published in:
- International Journal of Cancer, 2004, v. 111, n. 6, p. 934, doi. 10.1002/ijc.20366
- By:
- Publication type:
- Article
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 107, doi. 10.1177/1756287211407543
- By:
- Publication type:
- Article
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
- Published in:
- BJU International, 2022, v. 129, n. 4, p. 463, doi. 10.1111/bju.15428
- By:
- Publication type:
- Article
Phase II study of everolimus in metastatic urothelial cancer.
- Published in:
- BJU International, 2013, v. 112, n. 4, p. 462, doi. 10.1111/j.1464-410X.2012.11720.x
- By:
- Publication type:
- Article
Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 430, doi. 10.1159/000514345
- By:
- Publication type:
- Article
Correction: Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The histone deacetylase inhibitor belinostat (PXD101) suppressesbladder cancer cell growth in vitro and in vivo.
- Published in:
- Journal of Translational Medicine, 2007, v. 5, p. 49, doi. 10.1186/1479-5876-5-49
- By:
- Publication type:
- Article
Genomic characterization of response to chemoradiation in urothelial bladder cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 4, p. 981, doi. 10.1002/cncr.26375
- By:
- Publication type:
- Article
Sequential Adjuvant Chemotherapy After Surgical Resection of High-Risk Urothelial Carcinoma.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 22, p. 5193, doi. 10.1002/cncr.24570
- By:
- Publication type:
- Article
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Advanced Bladder Cancer: Status of First-line Chemotherapy and the Search for Active Agents in the Second-line Setting.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 6, p. 1284, doi. 10.1002/cncr.23692
- By:
- Publication type:
- Article
Testicular Seminoma: A Clinicopathologic and Immunohistochemical Study of 105 Cases with Special Reference to Seminomas with Atypical Features.
- Published in:
- International Journal of Surgical Pathology, 2002, v. 10, n. 1, p. 23, doi. 10.1177/106689690201000105
- By:
- Publication type:
- Article
Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 483, doi. 10.1002/onco.13719
- By:
- Publication type:
- Article
The Safety and Efficacy of Single-Agent Pemetrexed in Platinum-Resistant Advanced Urothelial Carcinoma: A Large Single-Institution Experience.
- Published in:
- Oncologist, 2015, v. 20, n. 5, p. 508, doi. 10.1634/theoncologist.2014-0354
- By:
- Publication type:
- Article
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 608, p. 1, doi. 10.1126/scitranslmed.abf5107
- By:
- Publication type:
- Article
A multifactorial model of T cell expansion and durable clinical benefit in response to a PD-L1 inhibitor.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0208422
- By:
- Publication type:
- Article
Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 24, p. 3952, doi. 10.1002/cncr.34991
- By:
- Publication type:
- Article
A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 20, p. 4532, doi. 10.1002/cncr.33071
- By:
- Publication type:
- Article
Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 7, p. 499, doi. 10.1093/jnci/djt015
- By:
- Publication type:
- Article